Yestar Healthcare Holdings Company Limited logo

Yestar Healthcare Holdings Company Limited (2393)

Market Open
9 Dec, 05:35
HKEX HKEX
0. 12
HKD
-0
-0.83%
HKD
289.12M Market Cap
- P/E Ratio
0.22% Div Yield
127,500 Volume
- Eps
0.12 HKD
Previous Close
Day Range
0.11 0.12
Year Range
0.06 0.2
Want to track 2393 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2393 trading today lower at 0.12 HKD, a decrease of 0.83% from yesterday's close, completing a monthly increase of 3.45% or 0 HKD. Over the past 12 months, 2393 stock gained 103.39%.
2393 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

2393 Chart

Similar

Modern Chinese Medicine Group Co., Ltd.
0.57 HKD
0%
Aidigong Maternal & Child Health Limited
1.31 HKD
-0.76%
Tycoon Group Holdings Ltd.
0.26 HKD
0%
Broncus Holding Corporation
2.45 HKD
0%
Meihao Medical Group Co., Ltd.
0.4 HKD
+6.76%

Yestar Healthcare Holdings Company Limited (2393) FAQ

What is the stock price today?

The current price is 0.12 HKD.

On which exchange is it traded?

Yestar Healthcare Holdings Company Limited is listed on HKEX.

What is its stock symbol?

The ticker symbol is 2393.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.22%.

What is its market cap?

As of today, the market cap is 289.12M.

Has Yestar Healthcare Holdings Company Limited ever had a stock split?

No, there has never been a stock split.

Yestar Healthcare Holdings Company Limited Profile

Health Care Providers & Services Industry
Healthcare Sector
Mr. Chunlai Wang CEO
HKEX Exchange
- ISIN
China Country
479 Employees
- Last Dividend
16 Dec 2014 Last Split
- IPO Date

Overview

Yestar Healthcare Holdings Company Limited, headquartered in Shanghai, People's Republic of China, is a formidable enterprise in the healthcare sector. Initiated in 1971, the company was previously known as Yestar International Holdings Company Limited until it underwent a rebranding in January 2017. Operating primarily as an investment holding entity, Yestar Healthcare has carved a niche in manufacturing and distributing a broad array of medical imaging products across Mainland China. The company's operations are strategically divided into two key segments: Imaging Printing Products, and Medical Products and Equipment, catering to a diverse range of professional, medical, and industrial imaging needs. Besides its core activities, Yestar Healthcare also branches out into biotechnology product development, distribution of in vitro diagnostic products, supply chain management, and offering freight transportation services, highlighting its multifaceted approach within the healthcare industry.

Products and Services

  • Imaging Printing Products:

    This segment underlines Yestar Healthcare's capacity to manufacture and sell high-quality imaging products. The offerings include Fujifilm color photographic paper, industrial NDT x-ray films, and PWB films, alongside trading in imaging equipment. These products find their applications in professional photo labs, minilabs, and various industrial imaging functionalities. Additionally, the segment touts NDT X-ray films under the proprietary Yes!Star brand, showcasing Yestar's commitment to innovation and quality in the imaging spectrum.

  • Medical Products and Equipment:

    Yestar’s operation in this segment is comprehensive, encompassing the manufacture and sale of medical dry and wet films, dental films, alongside the distribution of medical equipment and diagnostic reagents. The rigorous selection and offering of these products demonstrate the company's dedication to supporting medical diagnostics and patient care, showcasing its role as a key player in enhancing healthcare quality through reliable medical supplies and technologies.

  • Biotechnology and In Vitro Diagnostic Products:

    The company's venture into biotechnology product development and the distribution of in vitro diagnostic products accentuates its focus on the cutting-edge research and advancements in healthcare. By engaging in these areas, Yestar Healthcare aims to contribute to the improvement of diagnostic methodologies and the broader development of innovative healthcare solutions, thereby meeting the evolving needs of the healthcare sector.

  • Supply Chain Management and Freight Transportation:

    Understanding the critical role of logistics in healthcare, Yestar provides specialized supply chain management services and freight transportation. This aspect of their services ensures the efficient and reliable distribution of their products, as well as those of other entities, reinforcing the company’s commitment to excellence and customer satisfaction in all facets of its operations.

Contact Information

Address: Green Land Building
Phone: 86 21 6489 0111